188 related articles for article (PubMed ID: 38181871)
1. Communication between nonalcoholic fatty liver disease and atherosclerosis: Focusing on exosomes.
Zhao X; Kong X; Cui Z; Zhang Z; Wang M; Liu G; Gao H; Zhang J; Qin W
Eur J Pharm Sci; 2024 Feb; 193():106690. PubMed ID: 38181871
[TBL] [Abstract][Full Text] [Related]
2. Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy.
Hernández A; Arab JP; Reyes D; Lapitz A; Moshage H; Bañales JM; Arrese M
Cells; 2020 Mar; 9(4):. PubMed ID: 32231001
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1.
Jiang F; Chen Q; Wang W; Ling Y; Yan Y; Xia P
J Hepatol; 2020 Jan; 72(1):156-166. PubMed ID: 31568800
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Vesicles as Inflammatory Drivers in NAFLD.
Srinivas AN; Suresh D; Santhekadur PK; Suvarna D; Kumar DP
Front Immunol; 2020; 11():627424. PubMed ID: 33603757
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicle therapy for obesity-induced NAFLD: a comprehensive review of current evidence.
Zhang J; Ma B; Wang Z; Chen Y; Li C; Dong Y
Cell Commun Signal; 2024 Jan; 22(1):18. PubMed ID: 38195552
[TBL] [Abstract][Full Text] [Related]
6. The role of exosomal miRNA in nonalcoholic fatty liver disease.
Mahmoudi A; Butler AE; Jamialahmadi T; Sahebkar A
J Cell Physiol; 2022 Apr; 237(4):2078-2094. PubMed ID: 35137416
[TBL] [Abstract][Full Text] [Related]
7. Small but significant: Insights and new perspectives of exosomes in cardiovascular disease.
Zhang J; Cui X; Guo J; Cao C; Zhang Z; Wang B; Zhang L; Shen D; Lim K; Woodfield T; Tang J; Zhang J
J Cell Mol Med; 2020 Aug; 24(15):8291-8303. PubMed ID: 32578938
[TBL] [Abstract][Full Text] [Related]
8. Hepatic steatosis aggravates atherosclerosis via small extracellular vesicle-mediated inhibition of cellular cholesterol efflux.
Chen X; Chen S; Pang J; Huang R; You Y; Zhang H; Xiao J; Xue H; Ling W
J Hepatol; 2023 Dec; 79(6):1491-1501. PubMed ID: 37678722
[TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicles characteristics and emerging roles in atherosclerotic cardiovascular disease.
Hafiane A; Daskalopoulou SS
Metabolism; 2018 Aug; 85():213-222. PubMed ID: 29727628
[TBL] [Abstract][Full Text] [Related]
10. Role of extracellular vesicles in nonalcoholic fatty liver disease.
Jiang W; Xu Y; Chen JC; Lee YH; Hu Y; Liu CH; Chen E; Tang H; Zhang H; Wu D
Front Endocrinol (Lausanne); 2023; 14():1196831. PubMed ID: 37534206
[TBL] [Abstract][Full Text] [Related]
11. microRNA profiles of serum exosomes derived from children with nonalcoholic fatty liver.
Zhang JW; Pan HT
Genes Genomics; 2022 Jul; 44(7):879-888. PubMed ID: 34390467
[TBL] [Abstract][Full Text] [Related]
12. Label-free quantitative proteomic analysis of serum extracellular vesicles differentiating patients of alcoholic and nonalcoholic fatty liver diseases.
Nguyen HQ; Lee D; Kim Y; Bang G; Cho K; Lee YS; Yeon JE; Lubman DM; Kim J
J Proteomics; 2021 Aug; 245():104278. PubMed ID: 34089894
[TBL] [Abstract][Full Text] [Related]
13. [Value of detection of extracellular vesicles in the diagnosis of nonalcoholic fatty liver disease].
Jiang WY; Xun YH
Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):92-96. PubMed ID: 32023709
[TBL] [Abstract][Full Text] [Related]
14. Extracellular vesicles: Novel mediator for cell to cell communications in liver pathogenesis.
Devhare PB; Ray RB
Mol Aspects Med; 2018 Apr; 60():115-122. PubMed ID: 29122679
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.
Mikolasevic I; Milic S; Racki S; Zaputovic L; Stimac D; Radic M; Markic D; Orlic L
Perit Dial Int; 2016; 36(4):427-32. PubMed ID: 26475841
[TBL] [Abstract][Full Text] [Related]
16. Exosomes: An emerging factor in atherosclerosis.
Wang Y; Xie Y; Zhang A; Wang M; Fang Z; Zhang J
Biomed Pharmacother; 2019 Jul; 115():108951. PubMed ID: 31078042
[TBL] [Abstract][Full Text] [Related]
17. A High-Fat Diet Attenuates AMPK α1 in Adipocytes to Induce Exosome Shedding and Nonalcoholic Fatty Liver Development In Vivo.
Yan C; Tian X; Li J; Liu D; Ye D; Xie Z; Han Y; Zou MH
Diabetes; 2021 Feb; 70(2):577-588. PubMed ID: 33262120
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease and cardiovascular disease.
Hyogo H; Chayama K; Yamagishi S
Curr Pharm Des; 2014; 20(14):2403-11. PubMed ID: 23844815
[TBL] [Abstract][Full Text] [Related]
19. Adipocyte exosomes induce transforming growth factor beta pathway dysregulation in hepatocytes: a novel paradigm for obesity-related liver disease.
Koeck ES; Iordanskaia T; Sevilla S; Ferrante SC; Hubal MJ; Freishtat RJ; Nadler EP
J Surg Res; 2014 Dec; 192(2):268-75. PubMed ID: 25086727
[TBL] [Abstract][Full Text] [Related]
20. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps.
Santos RD; Valenti L; Romeo S
Atherosclerosis; 2019 Mar; 282():110-120. PubMed ID: 30731283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
